Correlation Between Novozymes and Kraig Biocraft

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novozymes and Kraig Biocraft at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novozymes and Kraig Biocraft into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novozymes AS and Kraig Biocraft Labs, you can compare the effects of market volatilities on Novozymes and Kraig Biocraft and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novozymes with a short position of Kraig Biocraft. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novozymes and Kraig Biocraft.

Diversification Opportunities for Novozymes and Kraig Biocraft

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Novozymes and Kraig is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Novozymes AS and Kraig Biocraft Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kraig Biocraft Labs and Novozymes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novozymes AS are associated (or correlated) with Kraig Biocraft. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kraig Biocraft Labs has no effect on the direction of Novozymes i.e., Novozymes and Kraig Biocraft go up and down completely randomly.

Pair Corralation between Novozymes and Kraig Biocraft

Assuming the 90 days horizon Novozymes is expected to generate 4.17 times less return on investment than Kraig Biocraft. But when comparing it to its historical volatility, Novozymes AS is 4.6 times less risky than Kraig Biocraft. It trades about 0.03 of its potential returns per unit of risk. Kraig Biocraft Labs is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  10.00  in Kraig Biocraft Labs on August 27, 2024 and sell it today you would lose (1.00) from holding Kraig Biocraft Labs or give up 10.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Novozymes AS  vs.  Kraig Biocraft Labs

 Performance 
       Timeline  
Novozymes AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novozymes AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Kraig Biocraft Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kraig Biocraft Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Kraig Biocraft is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Novozymes and Kraig Biocraft Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novozymes and Kraig Biocraft

The main advantage of trading using opposite Novozymes and Kraig Biocraft positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novozymes position performs unexpectedly, Kraig Biocraft can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kraig Biocraft will offset losses from the drop in Kraig Biocraft's long position.
The idea behind Novozymes AS and Kraig Biocraft Labs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Correlations
Find global opportunities by holding instruments from different markets